It was previously reported that increased levels of FUS in vivo, either by overexpression or disruption of regulatory circuits, are associated with progressive motor neuron degeneration and ALS (51,78–80) and suggested that phase separation of FUS in the cytoplasm, followed by aggregation, drives disease (25,26). Here, FUS is linked to Motor neuron atrophy.